News & Updates
Showing Endocrinology articles
Showing

Digital intervention plus phentermine-topiramate cuts weight, CVD risk in adults with obesity
Combination treatment with phentermine-topiramate extended release (ER) and a digitally enhanced lifestyle intervention (DELI) results in a significant and sustained weight reduction, as well as a decrease in cardiovascular disease (CVD) risk, in adults with obesity, reports a study.

CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition
In an observational study of two community-based cohorts in Hong Kong, 6.7 percent of individuals with BMI ≥25 kg/m2 were reclassified as nonobese after applying the Lancet Commission’s definition of obesity. Individuals with clinical obesity had the highest risk of adverse cardiovascular-kidney-metabolic (CKM) outcomes, while those reclassified as nonobese had an intermediate risk.

Albuminuria an important fracture risk predictor in T2D
Albuminuria is an important and independent predictor of hip fractures and major osteoporotic fractures (MOF) in patients with type 2 diabetes (T2D), and the presence of additional metabolic syndrome (MetS)–related traits compounds this fracture risk, particularly in nonobese patients, a population-based retrospective cohort study in Hong Kong has shown.





